Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Safety

Combating Fake Drugs

by Britt E. Erickson
July 20, 2009 | A version of this story appeared in Volume 87, Issue 29

[+]Enlarge
Credit: Shutterstock
Credit: Shutterstock

FDA has issued draft guidance for industry on the use of physical-chemical identifiers (PCIDs), such as inks, pigments, and flavors, to combat the production of counterfeit drugs. PCIDs make it more difficult to duplicate drugs and make it easier to differentiate between genuine and fake ones. Some PCIDs are readily detectable by wholesalers or pharmacists, but others, such as chemicals used in products as molecular tags, can be detected only with special analytical instruments. FDA anticipates that many PCIDs will consist of ingredients such as food additives or colorants that already have established safety records. The guidance recommends that PCIDs have no medicinal effects and be used at the lowest level possible to minimize adverse effects. FDA is inviting comments regarding the use of PCIDs in pills and capsules. "Drug counterfeiting is a serious public health concern," FDA Commissioner Margaret A. Hamburg said in a statement. "We look forward to working with industry to help ensure that consumers are not exposed to products containing unknown, ineffective, or harmful ingredients."

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.